Volume 87, Issue 6, Pages (June 2015)

Slides:

Advertisements

Similar presentations

Reduced renal function in patients with simple renal cysts

Advertisements

LDL cholesterol in CKD—to treat or not to treat?

Beta blockers in the management of chronic kidney disease

KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient Christoph Wanner,

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Mitchell H. Rosner, W. Kline Bolton Kidney International

No difference in bleeding risk between subcutaneous enoxaparin and heparin for thromboprophylaxis in end-stage renal disease Kevin E. Chan, Ravi I. Thadhani,

Volume 83, Issue 3, Pages (March 2013)

Volume 87, Issue 5, Pages (May 2015)

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure Steven Fishbane, Nobuyuki Miyawaki Kidney International

Volume 91, Issue 1, Pages (January 2017)

C-reactive protein and dialysis access

Vitamin D deficiency and heart disease

Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh Kidney International

Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States Austin G. Stack, Bhamidipati V.R.

Volume 61, Issue 2, Pages (February 2002)

Reassessment of the care of the patient with chronic kidney disease

Volume 80, Issue 10, Pages (November 2011)

C-reactive protein and dialysis access

Smoking and cardiovascular outcomes in dialysis patients: The United States Renal Data System Wave 2 Study1,2 Robert N. Foley, Charles A. Herzog, Allan.

Homocysteine and risk in end-stage renal disease: a matter of context

End-stage renal disease in living kidney donors

Volume 80, Issue 9, Pages (November 2011)

Comorbidity and confounding in end-stage renal disease

Acute myocardial infarction in patients with chronic kidney disease: how are the most vulnerable patients doing? Gautam R. Shroff, Charles A. Herzog

Volume 74, Issue 3, Pages (August 2008)

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Volume 82, Issue 3, Pages (August 2012)

Volume 70, Issue 11, Pages (December 2006)

Renal risk scores: Progress and prospects

Long-term outcomes in nondiabetic chronic kidney disease

Volume 87, Issue 4, Pages (April 2015)

Volume 85, Issue 6, Pages (June 2014)

Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.

U-shaped effect of eGFR and mortality

LDL cholesterol in CKD—to treat or not to treat?

Volume 83, Issue 4, Pages (April 2013)

Volume 70, Issue 12, Pages (December 2006)

Volume 73, Issue 12, Pages (June 2008)

Volume 76, Issue 6, Pages (September 2009)

American Journal of Kidney Diseases

Effects of hemodialysis on cardiac function

Extracorporeal therapy in sepsis: are we there yet?

Volume 69, Issue 12, Pages (June 2006)

Volume 71, Issue 6, Pages (March 2007)

Volume 87, Issue 1, Pages (January 2015)

Racial disparities in access to transplantation: a tough nut to crack

Alfonso M. Cueto-Manzano, Ricardo Correa-Rotter Kidney International

Volume 76, Issue 8, Pages (October 2009)

Reduced renal function in patients with simple renal cysts

Nephrology Crossword: Glomerulonephritis

Volume 80, Issue 6, Pages (September 2011)

Volume 74, Issue 5, Pages (September 2008)

Volume 85, Issue 5, Pages (May 2014)

Volume 77, Issue 12, Pages (June 2010)

Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients B. Bammens, P. Evenepoel, H. Keuleers,

Volume 74, Issue 11, Pages (December 2008)

Low triiodothyronine and survival in end-stage renal disease

Volume 72, Issue 2, Pages (July 2007)

Does equal care give equal outcomes?

Volume 80, Issue 10, Pages (November 2011)

Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley

Fetuin-A is not associated with mortality in chronic kidney disease

Tobias Breidthardt, Alexandre Mebazaa, Christian E. Mueller

Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes Steven M. Brunelli, Ravi Thadhani,

Volume 70, Issue 10, Pages (November 2006)

Volume 76, Issue 5, Pages (September 2009)

Prediction in idiopathic membranous nephropathy

Volume 82, Issue 1, Pages (July 2012)

Volume 60, Issue 1, Pages (July 2001)

Presentation transcript:

Volume 87, Issue 6, Pages 1201-1208 (June 2015) Protein carbamylation is associated with heart failure and mortality in diabetic patients with end-stage renal disease Christiane Drechsler, Sahir Kalim, Julia B. Wenger, Pirianthini Suntharalingam, Tammy Hod, Ravi I. Thadhani, S. Ananth Karumanchi, Christoph Wanner, Anders H. Berg Kidney International Volume 87, Issue 6, Pages 1201-1208 (June 2015) DOI: 10.1038/ki.2014.429 Copyright © 2015 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier curve estimates of the incidence of sudden cardiac death and death due to congestive heart failure in Die Deutsche Diabetes Dialyse Studie patients. Subjects were categorized into upper, middle, and lower tertiles according to serum carbamylated albumin values measured at the outset of the study. (a) Mortality due to congestive heart failure. (b) Mortality due to sudden cardiac death. Kidney International 2015 87, 1201-1208DOI: (10.1038/ki.2014.429) Copyright © 2015 International Society of Nephrology Terms and Conditions